+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Anti-Infectives: Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives: Global Strategic Business Report

  • Report
  • April 2024
  • 116 Pages
  • Global
From
From
From
From
Post-surgical Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Post-surgical Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CNS Bacterial Infections - Pipeline Insight, 2024 - Product Thumbnail Image

CNS Bacterial Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hospital Acquired Candida Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Hospital Acquired Candida Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Staphylococcal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Staphylococcal Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Surgery Incisional Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Surgery Incisional Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Scedosporium Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Scedosporium Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Sternal Wound Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Sternal Wound Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Staphylococcus Aureus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Staphylococcus Aureus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Surgical Wound Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Surgical Wound Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Clostridium Difficile Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Clostridium Difficile Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Cytomegalovirus (CMV) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Cytomegalovirus (CMV) Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
Hepatitis C Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis C Virus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more